AGP Picks
View all

The Healthy Alaskan: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Healthy Alaskan.

Press releases published on September 9, 2026

Editas Medicine Reports Inducement Grants to New Chief Medical Officer
Femasys Partners with CapexMD to Expand Patient Access to FemaSeed® Fertility Portfolio
Mindera Health Collaborates with the University of Pennsylvania for Academic Research Exploring Cutaneous Lupus Erythematosus Treatment
SCIENTURE to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14, 2026
Quantum BioPharma Ltd. NASDAQ: QNTM) Receives FDA Clearance to Begin Trials for Historic MS Treatment
Intelligent Bio Solutions Submits FDA 510(k) Package for Intelligent Fingerprinting Drug Screening System, Seeking U.S. Market Clearance
Syncromune® Presents SYNC-T™ Therapy: Image-Guided Cryolysis and Intratumoral Immunotherapy at CIRSE 2026
Propanc Biopharma to Initiate World-First Phase 1b First-in-Human Study of PRP in February 2027
Sysmex Europe and Cytek® Biosciences Collaborate to Expand Access to Advanced Clinical Flow Cytometry
Trinity Biotech’s Trinovium Subsidiary Signs Contract to Supply Red Team Investments with Advanced Liquid Cooling Solutions for AI Data Center Infrastructure
ENvue Medical Resumes U.S. Commercial Shipments of NanoVibronix PainShield® and Begins Fulfilling Open Distributor Orders
IMUNON Announces Full Agenda and Speaker Lineup Ahead of 2026 R&D Day Highlighting IMNN-001 Clinical Progress
Nanox Announces Second Quarter 2026 Financial Results and Provides Business Updates
Monogram Health Publishes Inaugural Impact Report, Documenting Impressive Clinical and Financial Outcomes Resulting From Its In-Home Multispecialty Medical Group Care Model
Rezera Announces Ruvonoflast Met its Primary Inflammation Endpoint and Demonstrated Favorable Safety Profile in RESOLVE-1 Phase 2 Clinical Trial
ProQR Announces First Participant Dosed in Phase 1 Study of AX-0811 and Virtual Investor and Analyst Educational Event on September 30, 2026
Jasper Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Adagene Achieves Milestone in Collaboration with Exelixis for Advancement of SAFEbody® Antibody-Drug Conjugate Candidates
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
IN8bio Appoints Oxana Polyakova, Ph.D., as Senior Vice President of Research & Development

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Healthy Alaskan

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.